-
CD8+ Tumor-Infiltrating Lymphocyte Abundance is a Positive Prognostic Indicator in Nasopharyngeal Cancer
Study
EGAS00001006396
-
Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes
Study
EGAS00001005906
-
Hepatoblastoma tumoroid biobank as a key resource for tumour genetics
Study
EGAS00001008251
-
Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancers
Study
EGAS00001002604
-
Reduced Representation Bisulfite Sequencing (RRBS) in various tissues to discover DNA methylation markers for the diagnosis of breast and ovarian cancer.
Study
EGAS00001002609
-
The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.
Study
EGAS00001005230
-
The evolution of hematopoietic cells under cancer therapy
Study
EGAS00001005234
-
Non-coding mutations reveal cancer driver cistromes in luminal breast cancer
Study
EGAS00001005235
-
Sequencing of an adolescent patient with germline RET mutant alveolar rhabdomyosarcoma
Study
EGAS00001004359
-
TP53 variant detection analysis in high grade serous epithelial ovarian cancer
Study
EGAS00001004361
-
TCR β-chain repertoire characterization of regulatory and conventional T cells in peripheral blood from breast cancer patients and healthy individuals.
Study
EGAS00001002699
-
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
Study
EGAS00001005963
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
Epigenetic analyses of methylation and nucleosome occupancy in cell-free DNA (cfNOMe)
Study
EGAS00001004370
-
Nucleosome footprinting in plasma cell-free DNA for diagnosis of ovarian cancer
Study
EGAS00001005361
-
Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis
Study
EGAS00001004373
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
To determine the genomic profile of Triple Negative Breast Cancer patient-derived xenografts (PDX cohort)
Study
EGAS00001005995
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (RNA-seq)
Study
EGAS00001006016
-
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer
Study
EGAS00001005952
-
Subtype specific studies of breast cancer progression. Milan cohort.
Study
EGAS00001004390
-
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Study
EGAS00001004405
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Study
EGAS00001004406